Pär-Ola Bendahl
201 – 220 of 226
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
(
- Contribution to journal › Article
-
Mark
Validering av ny prognostisk modell i lymfkörtelnegativ bröstcancer baserad på automatiskt utvärderade DNA flödescytometriska data
2002) Svenska Läkaresällskapets Riksstämma(
- Contribution to conference › Poster
- 2001
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
(
- Contribution to journal › Article
-
Mark
DNA and cell cycle analysis as prognostic indicators in breast tumors revisited
(
- Contribution to journal › Article
-
Mark
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens
(
- Contribution to journal › Article
-
Mark
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase) : association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients
(
- Contribution to journal › Article
-
Mark
Image cytometric Auer class-I identifies a real low risk group among lymph node negative premenopausal breast cancer patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Histological grade, its three components and flow cytometric S-phase as prognostic markers in premenopausal women with node negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
- 1999
-
Mark
No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article
-
Mark
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article